Loading clinical trials...
Loading clinical trials...
This study aims to explore the effectiveness and safety of the in-hospital-out-of-hospital synergistic short-term insulin intensive therapy model based on patch insulin pump and continuous glucose monitoring technology through a randomized controlled study, and evaluate the possibility of blood glucose parameters derived from continuous glucose technology in predicting long-term blood glucose remission, so as to provide important reference data for the precision, intelligence, and integrated improvement of short-term insulin intensive therapy.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
刘烈华
Guandong, China
Start Date
March 7, 2023
Primary Completion Date
May 1, 2024
Completion Date
December 30, 2024
Last Updated
November 13, 2023
210
ESTIMATED participants
Insulin Glargine
DRUG
Metformin
DRUG
Dapagliflozin
DRUG
Insulin aspart
DRUG
Lead Sponsor
Sun Yat-sen University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions